Abstract Session 2

Co-Chair(s)

• 

  Niccolo Bolli, MD, PhD

  Associate Professor of Hematology
  University of Milan, Italy
• 

  Michel Delforge, MD/Phd (he/him/his)

  Professor of Medicine
  University of Leuven, Leuven, Belgium
  Leuven, Belgium

Presentations:

• 11:30 AM – 11:42 AM East Coast USA Time

  OA – 22: A single-cell atlas of bone marrow immune microenvironment characterizes dysregulation associated with multiple myeloma outcomes
  

  Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation
• 11:42 AM – 11:54 AM East Coast USA Time

  OA – 26: Single cell whole genome measurement of genomic heterogeneity and clonal evolution in multiple myeloma
  

  Speaker: Andrew McPherson, PhD – Memorial Sloan Kettering Cancer Center
• 11:54 AM – 12:06 PM East Coast USA Time

  OA – 28: MM progression and evolution of refractory disease explained by integrative multiomics in Moffitt Cancer Center's patient cohort
  

  Speaker: Ariosto Siqueira Silva, PhD – H. Lee Moffitt Cancer Center and Research Institute
• 12:06 PM – 12:18 PM East Coast USA Time

  OA – 39: Genomic landscape of IgM MGUS and stable versus progressive asymptomatic Waldenström macroglobulinemia patients
  

  Speaker: Tina Bagratuni, PhD (she/her/hers) – National and Kapodistrian University of Athens
• 12:18 PM – 12:30 PM East Coast USA Time

  OA – 56: Single cell analyses of bone marrow immune microenvironment in RRMM subjects treated with MEK1/2 inhibitors reveal IRF1-mediated IFN/PDL1 signaling axes
  

  Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation